Isabel Spriet
Impact in
- Geriatrics and Gerontology top 0.5%
- Pharmaceutical Practices and Patient Outcomes
- Infectious Diseases top 0.5%
- Antifungal resistance and susceptibility
- Antimicrobial Resistance in Staphylococcus
Papers in
-
- Antifungal resistance and susceptibility 50
- Antimicrobial Resistance in Staphylococcus 10
- Pharmacology 45
- Antibiotics Pharmacokinetics and Efficacy 39
- Co-authors
- Johan Maertens (26 shared papers)Katrien Lagrou (35 shared papers)Ludo Willems (33 shared papers)Wouter Meersseman (14 shared papers)Joost Wauters (41 shared papers)Pieter Annaert (27 shared papers)Eric Van Wijngaerden (11 shared papers)Eric Verbeken (3 shared papers)
- Journals
- Antibiotics (12 papers)International Journal of Clinical Pharmacy (11 papers)Mycoses (8 papers)Journal of Antimicrobial Chemotherapy (8 papers)Infection (6 papers)
- Partner nations
- BelgiumNetherlandsUnited States
In The Last Decade
Isabel Spriet
176 papers receiving 4.2k citations
Peers
Comparison fields: 5 of 137
- Geriatrics and Gerontology 361
- Infectious Diseases 1.5k
- Applied Microbiology and Biotechnology 137
- Pharmacology 686
- Epidemiology 1.0k
Countries citing papers authored by Isabel Spriet
This map shows the geographic impact of Isabel Spriet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Spriet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Spriet more than expected).
Fields of papers citing papers by Isabel Spriet
This network shows the impact of papers produced by Isabel Spriet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Spriet. The network helps show where Isabel Spriet may publish in the future.
Co-authors
The 25 scholars most cited alongside Isabel Spriet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 197 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 352 | |
| 2 | 2019 | 162 | |
| 3 | 2012 | 145 | |
| 4 | 2009 | 139 | |
| 5 | 2019 | 126 | |
| 6 | 2018 | 121 | |
| 7 | 2009 | 115 | |
| 8 | 2011 | 115 | |
| 9 | 2010 | 113 | |
| 10 | 2017 | 109 | |
| 11 | 2010 | 86 | |
| 12 | 2020 | 85 | |
| 13 | 2014 | 78 | |
| 14 | 2017 | 71 | |
| 15 | 2022 | 66 | |
| 16 | 2008 | 61 | |
| 17 | 2017 | 59 | |
| 18 | 2012 | 58 | |
| 19 | 2021 | 55 | |
| 20 | 2009 | 54 |
About Isabel Spriet
Isabel Spriet is a scholar working on Infectious Diseases, Pharmacology, Epidemiology, Geriatrics and Gerontology and Pulmonary and Respiratory Medicine, having authored 197 papers that have together received 4.3k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (50 papers), Antibiotics Pharmacokinetics and Efficacy (39 papers), Pharmaceutical Practices and Patient Outcomes (22 papers), Fungal Infections and Studies (14 papers), Pneumonia and Respiratory Infections (12 papers), Antimicrobial Resistance in Staphylococcus (10 papers), Antibiotic Resistance in Bacteria (9 papers) and Antibiotic Use and Resistance (6 papers). The work is most often cited by research in Geriatrics and Gerontology (361 citations), Infectious Diseases (1.5k citations), Applied Microbiology and Biotechnology (137 citations), Pharmacology (686 citations) and Epidemiology (1.0k citations). Isabel Spriet has collaborated with scholars based in Belgium, Netherlands and United States. Frequent co-authors include Johan Maertens, Katrien Lagrou, Ludo Willems, Wouter Meersseman, Joost Wauters, Pieter Annaert, Eric Van Wijngaerden, Eric Verbeken, Ruth Van Daele and Greet Hermans. Their work appears in journals such as Antibiotics, International Journal of Clinical Pharmacy, Mycoses, Journal of Antimicrobial Chemotherapy and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.